Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access
Login for full access:
- Sort by:
- Browse by:
- Paid users only
- purchase
- Available
- All slides included
Key questions for ctDNA analysis
Paul T Spellman
Oregon Health Science Univ., Portland, OR, United States
- Paid users only
- purchase
- Available
- All slides included
Title to be announced
Jamie Platt
Inivata, Research Triangle Park, NC, United States
- Paid users only
- purchase
- Available
- All slides included
The dual roles of analytical and clinical data in ctDNA test validation
Justin Odegaard
Guardant Health Inc., Redwood City, CA, United States
- Paid users only
- purchase
- Available
- Some slides withheld
Analytical validation of liquid biopsy assays: current challenges and opportunities
Mark Sausen
Personal Genome Diagnostics, Baltimore, MD, United States
- Paid users only
- purchase
- Available
- All slides included
Using large-scale mutagenesis to define cancer risk and understand inhibitor resistance
Douglas Fowler
University of Washington, Seattle, WA, United States
- Paid users only
- purchase
- Available
- All slides included
Escaping the confines of clinical genomics through massively-parallel variant phenotyping
Cory Matthew Johannessen
Broad Inst. of MIT and Harvard, Cambridge, MA, United States
- Paid users only
- purchase
- Available
- All slides included
Multiplexed functional assays to assess BRCA1 variants
Lea Starita
University of Washington, Seattle, WA, United States
- Paid users only
- purchase
- Available
- All slides included
CHASM plus reveals the scope of somatic missense mutations driving human cancers
Rachel Karchin
Johns Hopkins Univ., Baltimore, MD, United States
- Paid users only
- purchase
- Available
- All slides included
The evolving landscape of biomarker selection in immunotherapy treatment decisions
Leena Gandhi
Lilly Oncology, Boston, MA, United States
- Paid users only
- purchase
- Available
- All slides included
Predicting immunotherapy response with protein-based tools: PD-L1 and beyond
David L. Rimm
Yale Univ. School of Medicine, New Haven, CT, United States
- Paid users only
- purchase
- Available
- All slides included
Cancer immunoediting: Framing response and resistance in immunotherapy
Gavin P. Dunn
Washington Univ. School of Medicine, Saint Louis, MO, United States
- Paid users only
- purchase
- Available
- All slides included
Improving precision immuno-oncology using novel technologies
David A. Barbie
Dana-Farber Cancer Inst., Boston, MA, United States
- Permission not
granted for presentation
Cancer therapeutics: A view from the microbiota
Christian Jobin
Univ. of Florida, Gainesville, FL, United States
- Paid users only
- purchase
- Available
- All slides included
Dynamic monitoring of the dysbiotic microbiome
Jonathan Braun
Mt. Sinai Medical Center, Los Angeles, CA, United States
- Paid users only
- purchase
- Available
- All slides included
Identification and targeting microbial vulnerabilities
Ami S Bhatt
Stanford Medical School, Stanford, CA, United States
- Paid users only
- purchase
- Available
- All slides included
Encapsulated fecal transplant: It's not just for Clostridium difficile any more!
Elizabeth L Hohmann
Massachusetts General Hospital, Boston, MA, United States
- Paid users only
- purchase
- Available
- All slides included
Introduction
Massimo Loda
Cornell Univ., Ithaca, NY, United States
- Paid users only
- purchase
- Available
- All slides included
Pathology for cancer researchers: An overview
Jiaoti Huang
Duke Univ. School of Medicine, Durham, NC, United States
- Paid users only
- purchase
- Available
- All slides included
Antibody validation of immunohistochemistry (IHC) and in situ hybridization assays in tissue: Pitfalls, tips, and techniques
Angelo M De Marzo
John Hopkins Univ. School of Medicine, Baltimore, MD, United States
- Paid users only
- purchase
- Available
- All slides included
Molecular pathology and diagnostics
Andrea L Richardson
Johns Hopkins Univ. School of Medicine, Washington, DC, United States
- Paid users only
- purchase
- Available
- All slides included
Computational pathology, imaging, and artificial intelligence
Andrew H Beck
PathAI, Cambridge, MA, United States
- Paid users only
- purchase
- Available
- All slides included
Tracking the arc of leukemia development from the beginning to the end
John E Dick
Univ. of Toronto, Toronto, ON, Canada
- Paid users only
- purchase
- Available
- All slides included
Quantifying clonal dynamics through treatment and metastasis
Christina Curtis
Stanford University, Stanford, CA, United States
- Paid users only
- purchase
- Available
- All slides included
Reconstructing the life history of cancers
Moritz Gerstung
European Bioinformatics Institute, Hinxton, Cambridgeshire, United Kingdom
- Paid users only
- purchase
- Available
- All slides included
Evolution and heterogeneity in glioblastomas
Raul Rabadan
Columbia Univ. Medical Ctr., New York, NY, United States